Secondary hyperparathyroidism (SHPT) is a common complication of chronic kidney disease (CKD), for which there are unmet needs surrounding its management. Four posters presented at international congresses in 2019 and 2020 investigated the management of SHPT, including the efficacy and safety of current and future treatments.
Latest articles
All articles
12 Mins
20
Jul
Editor’s Pick: Blood Volume Monitoring: A Clinical Tool to Guide Ultrafiltration in Volume Control and Optimisation of Intradialytic Blood Pressure
The use of BVM dates back to the early 1990s when CRIT-LINE® technology (Fresenius Medical Care, Bad Homburg, Germany) was first used as a non-invasive method of measuring haematocrit changes during haemodialysis, in real time, by connection of an additional monitor to the dialysis arterial line set-up.
18 Mins
20
Jul
Trace Elements and Chronic Kidney Disease: A Cross-Sectional Study from Jamaica
Trace elements are ubiquitous entities and a fair number of non-essential xenobiotics gain entry into the body via a multitude of ways, including through groundwater (arsenic, strontium, silicon), inhalation of silica dust (silicon), gasoline (lead), cigarette smoke, and soil (cadmium) and food contamination (arsenic, mercury).